+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 75Years
All Genders
ID07587125

Exploring Safety and Effects of S103 CAR-T Cell Therapy for Adults with Progressive or Refractory Multiple Sclerosis

Led by Xijing Hospital · Updated on 2026-08-05

9

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, and preliminary effectiveness of S103 BCMA-CAR T cells in adults with progressive or refractory multiple sclerosis MS. This exploratory Phase 1 study uses a dose escalation design to explore the safety profile and dose-limiting toxicities of the treatment. The trial enrolls adult patients with progressive or refractory MS who have limited treatment options and aims to recruit a total of 9 patients. Participants will undergo leukapheresis followed by lymphodepletion conditioning with cyclophosphamide and fludarabine. After this, they will receive an infusion of S103 CAR-T cells at varying doses ranging from 0.5 to 2.0 million CAR-T cells per kilogram. The study uses a standard 33 dose escalation design to evaluate increasing doses. The treatment period includes active monitoring for safety and response over several weeks post-infusion. During the study, participants will be closely monitored for side effects and dose-limiting toxicities from Day 1 up to 28 days after infusion, with further safety assessments continuing up to 26 weeks. Researchers will also evaluate biomarkers and disability status changes using the Expanded Disability Status Scale EDSS. Assessments include physical exams, vital signs, lab tests, electrocardiograms, echocardiograms, and multiple biomarker measurements. Participants are followed for approximately six months to assess treatment impact and safety.

CONDITIONS

Brief Title

Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis

Research Team

W

Wen Jiang Dr.

X

Xiaodan Shi Dr.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here